• HOME
  • FAQs
  • NEWS
  • FULL PRESCRIBING INFORMATION
  • About VETMEDIN
    • Dual-acting inodilator
    • VETMEDIN
      in CHF
    |
  • About CHF|
    • Signs of CHF
    • AVVI
    • DCM
    • Diagnosing CHF
  • Act Now—Use VETMEDIN|
    • CHF treatment
    • Importance of acting now
    • 2009 ACVIM consensus statement
  • VETMEDIN Efficacy|
    • VetSCOPE
    • QUEST
  • Safety and Dosing|
    • Record of safe use
    • Dosage
  • VETMEDIN Programs
  • Signs of CHF
  • AVVI
  • DCM
  • Diagnosing CHF
    • Clinical history
    • Physical examination
    • Cardiac and pulmonary auscultation
    • Thoracic radiographs
    • Additional diagnostic tests

USEFUL LINKS

  • VETMEDIN Full Prescribing
    Information
  • Cardiac Education Group
  • YourDogsHeart.com
  • Boehringer Ingelheim Vetmedica, Inc.
  • American College of Veterinary
    Internal Medicine

Diagnosing CHF

Early detection and treatment are key

Unfortunately, common clinical signs of congestive heart failure (CHF), such as coughing and difficulty breathing, are nonspecific and may mimic respiratory disease, making diagnosis difficult.1,2

Following a series of key steps and using some of the latest diagnostic tools recommended by the Cardiac Education Group (CEG) and other cardiologists can help you identify and treat CHF earlier in canine patients.1,3 The CEG recommends the following diagnostic tools as essential for diagnosing CHF:

  1. Clinical history
  2. Physical examination
  3. Cardiac and pulmonary auscultation
  4. Thoracic radiographs
  5. Additional diagnostic tests

References:

1. Oyama MA, Rush JE, Rozanski EA, et al. Assessment of serum N-terminal pro-B-type natriuretic peptide concentration for differentiation of congestive heart failure from primary respiratory tract disease as the cause of respiratory signs in dogs. J Am Vet Med Assoc. 2009;235(11):1319–1325. 2. Sisson D. Valvular heart disease in dogs. Proceedings from the WSAVA 2002 Congress; October 3–6, 2002; Granada, Spain. www.vin.com/ proceedings/Proceedings.plx?CID=WSAVA2002&PID=2532. Accessed January 21, 2011. 3. Cardiac Education Group. Canine cardiac diagnostic system: ABCD’s of canine cardiology. September 2010. Available at: www.cardiaceducationgroup.org/common/cms/documents/ ABCD_CEG_Brochurev13_R.pdf. Accessed January 17, 2011.

Important safety information

VETMEDIN should not be given in case of hypertrophic cardiomyopathy, aortic stenosis, or any other clinical condition where an augmentation of cardiac output is inappropriate for functional or anatomical reasons. The safety of VETMEDIN has not been established in dogs with asymptomatic heart disease or in heart failure caused by etiologies other than atrioventricularvalvular insufficiency or dilated cardiomyopathy. The safe use of VETMEDIN has not been evaluated in dogs younger than 6 months of age, dogs with congenital heart defects, dogs with diabetes mellitus or other serious metabolic diseases, dogs used for breeding, or pregnant or lactating bitches. Use only in dogs with clinical evidence of heart failure. The most common side effects reported in field studies were poor appetite, lethargy, diarrhea, dyspnea, azotemia, weakness, and ataxia. If side effects should occur, pet owners should contact their veterinarian. Please refer to the Full Prescribing Information here.

Home Site Map Terms of Use Privacy Contact About Boehringer Ingelheim Vetmedica,Inc.
VETMEDIN is a registered trademark of Boehringer Ingelheim Vetmedica GmbH, licensed to Boehringer Ingelheim Vetmedica, Inc.
© 2015 Boehringer Ingelheim Vetmedica, Inc.